Company Profile

NexGen Arrays LLC
Profile last edited on: 7/31/2019      CAGE: 71AC8      UEI: X31NKDU9Y3L5

Business Identifier: Virus diagnostic platform based on nanoparticalsL focus on Hemmorhagic Fevers such as Ebola
Year Founded
2013
First Award
2015
Latest Award
2015
Program Status
Inactive
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

8 Street Mary's Street
Boston, MA 02135
   (617) 903-0397
   dfreedman@nexgenarrays.com
   nexgenarrays.com
Location: Single
Congr. District: 07
County: Suffolk

Public Profile

NexGen Arrays has developed the Single Partice Interferometric Reflectance Imaging Sensor (SP-IRIS), a virus diagnostic platform based on the detection of single nanoparticles. The company's technology has demonstrated single virus and single molecule (proteins and nucleic acids) detection at clinical levels and is being developed for application to a Viral Hemmorhagic Fever panel including Ebola, Lassa, and Marburg. The SP-IRIS platform allows for detection of multiple targets on a single substrate, label-free detection, direct detection from complex fluids, and single-particle detection of small molecules. NexGen emphasizes the importance of rapid, multiplexed diagnostics that can be used by novice users in order to provide faster treatment in time-sensitive treatment scenerios.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
5-9
Revenue Range
.5M-1M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Key People / Management

  George Daaboul -- Chief Scientific Officer and Founder

  David Freedman -- Chief Executive Officer, Founder

Company News

There are no news available.